OGJ patients who had a poor pathologic response to treatment had significantly higher levels of tumour-infiltrating CD3+CD8+CD45RA+ T cells (50.82 ± 14.7 vs. 8.47 ± 2.0%, p = 0.03), (Fig. 6D) and terminally differentiated effector memory T cells (45.05 ± 12.9 vs. 7.76 ± 1.8%, p = 0.03) compared with good responders (Fig. 6E). This evidence concerns the gene CD8A and neoplasm.